Prof. Peter J. Little AM

Citata da

	Tutte	Dal 2020
Citazioni	15049	7016
Indice H	69	44
i10-index	212	125

1900

950

475

1425

198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202542 52 67 59 79 101 94 93 110 87 116 117 108 122 117 107 91 141 138 200 134 214 242 209 303 240 342 448 372 463 627 636 705 781 940 1058 1361 1480 1879 286

Accesso pubblico

Visualizza tutto

76 articoli

20 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Suowen XuUniversity of Science and Technology of ChinaEmail verificata su ustc.edu.cn
Danielle KamatoNational Heart Foundation - Future Leader Fellow and Group Leader, Griffith University; GriffithEmail verificata su griffith.edu.au
Mandy and BallingerGroup Leader, Genetic Cancer Risk, Garvan Institute of Medical ResearchEmail verificata su garvan.org.au
Hang Thu TaProfessor, Heart Foundation Future Leader FellowEmail verificata su griffith.edu.au
Rodney DilleyUniversity of Western AustraliaEmail verificata su uwa.edu.au
Hossein Babaahmadi-RezaeiDepartment of Medical Biochemistry, Ahvaz Jundishapur University of Medical Sciences, Ahvaz IranEmail verificata su ajums.ac.ir
Rizwana Afroz, PhDPostdoctoral Associate, Yale University, United StatesEmail verificata su yale.edu
Garry JenningsBaker Heart and Diabetes InstituteEmail verificata su baker.edu.au
Anthony DartAlfred Hospital & BakerIDI, Melbourne, AustraliaEmail verificata su alfred.org.au
Neale CohenBakerIDI Heart and Diabetes InstitiuteEmail verificata su baker.edu.au
Mohd FarhanPostdoctoral Research Associate at Georgetown University Washington, D.C.Email verificata su georgetown.edu
Murray EslerSenior Director Baker IDI Heart and Diabetes InstituteEmail verificata su bakeridi.edu.au
John R BendDistinguished University Professor, Emeritus of Pathology Western UniversityEmail verificata su schulich.uwo.ca
Susan G. GraySchool of Pharmacy, University of QueenslandEmail verificata su uqconnect.edu.au
Jacques PouyssegurIRCAN, Centre A. Lacassagne, University of Nice and Centre Scientifique de Monaco (CSM)Email verificata su unice.fr
Chris YunProfessor of Medicine, Emory UniversityEmail verificata su emory.edu
Mark DonowitzProfessor of Medicine and Physiology, Johns Hopkins University School of MedicineEmail verificata su jhmi.edu
Margaret Anne BrimbleSchool of Biological Sciences, School of Chemical Sciences, the University of Auckland,Email verificata su auckland.ac.nz
Karin Agnes JandeleitDepartment of Diabetes, Central Clinical School, Monash UniversityEmail verificata su monash.edu
Grant MorahanCentre for Diabetes Research, Uni of Western Australia, The Harry Perkins Institute for MedicalEmail verificata su uwa.edu.au

Segui

Prof. Peter J. Little AM

School of Pharmacy, The University of Queensland

Email verificata su uq.edu.au - Home page

Diabetes complications atherosclerosis glycosaminoglycans proteoglycans pharmacy practice


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies S Xu, I Ilyas, PJ Little, H Li, D Kamato, X Zheng, S Luo, Z Li, P Liu, J Han, ... Pharmacological reviews 73 (3), 924-967, 2021	736	2021
FOXO signaling pathways as therapeutic targets in cancer M Farhan, H Wang, U Gaur, PJ Little, J Xu, W Zheng International journal of biological sciences 13 (7), 815, 2017	469	2017
Insulin resistance and atherosclerosis J Nigro, N Osman, AM Dart, PJ Little Endocrine reviews 27 (3), 242-259, 2006	462	2006
Cardiovascular actions and therapeutic potential of tanshinone IIA S Gao, Z Liu, H Li, PJ Little, P Liu, S Xu Atherosclerosis 220 (1), 3-10, 2012	398	2012
Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation D Kamato, ML Burch, TJ Piva, HB Rezaei, MA Rostam, S Xu, W Zheng, ... Cellular signalling 25 (10), 2017-2024, 2013	329	2013
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers S Xu, S Ogura, J Chen, PJ Little, J Moss, P Liu Cellular and Molecular Life Sciences 70, 2859-2872, 2013	326	2013
Cloning and expression of a rabbit cDNA encoding a serum-activated ethylisopropylamiloride-resistant epithelial Na+/H+ exchanger isoform (NHE-2) CM Tse, SA Levine, CH Yun, MH Montrose, PJ Little, J Pouyssegur, ... Journal of Biological Chemistry 268 (16), 11917-11924, 1993	279	1993
Zinc and cardiovascular disease PJ Little, R Bhattacharya, AE Moreyra, IL Korichneva Nutrition 26 (11-12), 1050-1057, 2010	274	2010
Effect of moderate alcohol upon obstructive sleep apnoea MF Scanlan, T Roebuck, PJ Little, JR Redman, MT Naughton European respiratory journal 16 (5), 909-913, 2000	274	2000
Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-β1 exhibit increased binding to LDLs PJ Little, L Tannock, KL Olin, A Chait, TN Wight Arteriosclerosis, thrombosis, and vascular biology 22 (1), 55-60, 2002	210	2002
Naringenin and naringin in cardiovascular disease prevention: A preclinical review RH Moghaddam, Z Samimi, SZ Moradi, PJ Little, S Xu, MH Farzaei European Journal of Pharmacology 887, 173535, 2020	181	2020
Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis ME Ivey, N Osman, PJ Little Atherosclerosis 199 (2), 237-247, 2008	180	2008
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential X Ma, Z Liu, I Ilyas, PJ Little, D Kamato, A Sahebka, Z Chen, S Luo, ... International journal of biological sciences 17 (8), 2050, 2021	172	2021
Targeting mechanosensitive transcription factors in atherosclerosis N Niu, S Xu, Y Xu, PJ Little, ZG Jin Trends in pharmacological sciences 40 (4), 253-266, 2019	167	2019
The possible role of the Akt signaling pathway in schizophrenia W Zheng, H Wang, Z Zeng, J Lin, PJ Little, LK Srivastava, R Quirion Brain research 1470, 145-158, 2012	159	2012
Structure, function, pharmacology, and therapeutic potential of the G protein, Gα/q, 11 D Kamato, L Thach, R Bernard, V Chan, W Zheng, H Kaur, M Brimble, ... Frontiers in Cardiovascular Medicine 2, 129046, 2015	157	2015
Impact of sleep apnea on sympathetic nervous system activity in heart failure P Solin, DM Kaye, PJ Little, P Bergin, M Richardson, MT Naughton Chest 123 (4), 1119-1126, 2003	140	2003
Endothelial function and dysfunction: Impact of metformin A Nafisa, SG Gray, Y Cao, T Wang, S Xu, FH Wattoo, M Barras, N Cohen, ... Pharmacology & therapeutics 192, 150-162, 2018	139	2018
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics S Xu, D Kamato, PJ Little, S Nakagawa, J Pelisek, ZG Jin Pharmacology & therapeutics 196, 15-43, 2019	138	2019
Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis H Jiang, Y Zhou, SM Nabavi, A Sahebkar, PJ Little, S Xu, J Weng, J Ge Frontiers in Cardiovascular Medicine 9, 925923, 2022	133	2022

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori